ID: ALA442473

Max Phase: Preclinical

Molecular Formula: C53H85N7O11

Molecular Weight: 996.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)O)C(C)C)[C@@H](C)O

Standard InChI:  InChI=1S/C53H85N7O11/c1-6-7-8-9-10-11-12-13-14-15-16-17-21-27-44(64)58-46(36(4)61)52(69)59-45(35(2)3)50(67)60-47(37(5)62)51(68)56-42(33-39-28-30-40(63)31-29-39)49(66)55-41(26-22-23-32-54)48(65)57-43(53(70)71)34-38-24-19-18-20-25-38/h18-20,24-25,28-31,35-37,41-43,45-47,61-63H,6-17,21-23,26-27,32-34,54H2,1-5H3,(H,55,66)(H,56,68)(H,57,65)(H,58,64)(H,59,69)(H,60,67)(H,70,71)/t36-,37-,41+,42+,43+,45+,46+,47+/m1/s1

Standard InChI Key:  ZNCWQWCMFDOVGB-SNPCEKNGSA-N

Associated Targets(non-human)

Proteasome Macropain subunit PRE2 43 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 996.30Molecular Weight (Monoisotopic): 995.6307AlogP: 4.20#Rotatable Bonds: 37
Polar Surface Area: 298.61Molecular Species: ZWITTERIONHBA: 11HBD: 11
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.70CX Basic pKa: 17.64CX LogP: 3.28CX LogD: 3.27
Aromatic Rings: 2Heavy Atoms: 71QED Weighted: 0.04Np Likeness Score: 0.22

References

1. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R..  (2006)  Development of lipopeptides for inhibiting 20S proteasomes.,  16  (12): [PMID:16630721] [10.1016/j.bmcl.2006.03.033]

Source